je.st
news
Tag: formulation
Cosmetic Formulation
2016-09-01 09:06:09| Happi Breaking News
Tags: formulation
cosmetic
cosmetic formulation
In-Cosmetics North America Tackles Formulation Issues
2016-08-24 17:00:00| Happi Breaking News
Learn more about the newest techniques next month
Tags: north
issues
america
north america
Ice Plant Fuels New Formulation
2016-08-12 16:00:00| Happi Breaking News
Dr. Hauschka targets mass market for OTC skin care.
Tags: ice
plant
formulation
fuels
Data for Merck's Investigational Once-Daily Formulation of ISENTRESS (raltegravir) Show That at Week 48, a Regimen Containing the Once-Daily Dosing Formulation...
2016-07-22 13:00:00| Merck.com - Research & Development News
Dateline City: KENILWORTH, N.J. Resulted in Non-Inferior Efficacy and Safety to a Regimen Containing the Approved Twice-Daily Formulation EMA Accepts File Application, Plans Underway to Submit for Licensure to FDA This Year KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced efficacy and safety data in previously untreated adults with HIV-1 infection for the companys investigational once-daily formulation of ISENTRESS (raltegravir), known as raltegravir 600 mg (to be given as 2 x 600 mg), from the ongoing Phase 3 pivotal trial called ONCEMRK. Language: English Contact: MerckMedia:Pam Eisele, 267-305-3558Carmen de Gourville, 267-305-4195orInvestors:Teri Loxam, 908-740-1986Amy Klug, 908-740-1898 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Anticipating The Formulation Challenges Of Complex Molecules
2016-06-07 10:29:46| drugdiscoveryonline Home Page
By Anil Kane, Executive Director, Global Head of Formulation Sciences Pharmaceutical Development Services, and Andreas Stolle, Vice President of API Process Development Services, Stephen Closs, Senior Director, Global Technical Operations If formulation problems surface late in the process of turning active pharmaceutical ingredients (APIs) into beneficial drug products, developers may have to go back and change their API production processes. In the worst cases, Phase 1 and Phase 2 trials may have to be redone. And due to the increasing complexity of today’s API molecules, formulation problems are arising with greater frequency, delaying development, and burdening developers with unanticipated and heavy costs.
Tags: complex
challenges
formulation
molecules
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] next »